ASX - By Stock
|
KCN |
Re:
Flying
|
|
contrapuntal
|
37 |
10K |
1 |
07/08/25 |
07/08/25 |
ASX - By Stock
|
37
|
10K
|
1
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Chatree delivers another 20k ounce quarter & FY25 production
|
|
contrapuntal
|
30 |
11K |
1 |
15/07/25 |
15/07/25 |
ASX - By Stock
|
30
|
11K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Telix Intelligence
|
|
contrapuntal
|
365 |
125K |
11 |
14/07/25 |
14/07/25 |
ASX - By Stock
|
365
|
125K
|
11
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
contrapuntal
|
3.6K |
1.5M |
11 |
02/07/25 |
02/07/25 |
ASX - By Stock
|
3.6K
|
1.5M
|
11
|
|
ASX - By Stock
|
KCN |
Re:
General discussion
|
|
contrapuntal
|
7.5K |
2.9M |
3 |
30/06/25 |
30/06/25 |
ASX - By Stock
|
7.5K
|
2.9M
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
contrapuntal
|
3.6K |
1.5M |
2 |
26/06/25 |
26/06/25 |
ASX - By Stock
|
3.6K
|
1.5M
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: SABRE topline results
|
|
contrapuntal
|
46 |
18K |
10 |
13/06/25 |
13/06/25 |
ASX - By Stock
|
46
|
18K
|
10
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Investor Day Presentation
|
|
contrapuntal
|
20 |
11K |
3 |
11/06/25 |
11/06/25 |
ASX - By Stock
|
20
|
11K
|
3
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Update - Notification of buy-back - KCN
|
|
contrapuntal
|
13 |
4.4K |
4 |
27/05/25 |
27/05/25 |
ASX - By Stock
|
13
|
4.4K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
contrapuntal
|
3.6K |
1.5M |
13 |
22/05/25 |
22/05/25 |
ASX - By Stock
|
3.6K
|
1.5M
|
13
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Update - Notification of buy-back - KCN
|
|
contrapuntal
|
30 |
11K |
4 |
22/05/25 |
22/05/25 |
ASX - By Stock
|
30
|
11K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
contrapuntal
|
3.6K |
1.5M |
1 |
17/05/25 |
17/05/25 |
ASX - By Stock
|
3.6K
|
1.5M
|
1
|
|
ASX - By Stock
|
KCN |
Re:
Ann: March 2025 Quarterly Report
|
|
contrapuntal
|
90 |
32K |
22 |
02/05/25 |
02/05/25 |
ASX - By Stock
|
90
|
32K
|
22
|
|
ASX - By Stock
|
KCN |
Re:
Ann: On Market Share Buy-Back
|
|
contrapuntal
|
109 |
40K |
4 |
01/05/25 |
01/05/25 |
ASX - By Stock
|
109
|
40K
|
4
|
|
ASX - By Stock
|
KCN |
Re:
ASX is on notice about manipulation of Kingsgate share price
|
|
contrapuntal
|
1.1K |
430K |
3 |
17/04/25 |
17/04/25 |
ASX - By Stock
|
1.1K
|
430K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Change in substantial holding
|
|
contrapuntal
|
15 |
6.0K |
0 |
03/04/25 |
03/04/25 |
ASX - By Stock
|
15
|
6.0K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
contrapuntal
|
3.6K |
1.5M |
5 |
11/03/25 |
11/03/25 |
ASX - By Stock
|
3.6K
|
1.5M
|
5
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Increased Mineralisation at Chatree South-East Complex
|
|
contrapuntal
|
66 |
21K |
15 |
04/03/25 |
04/03/25 |
ASX - By Stock
|
66
|
21K
|
15
|
|
ASX - By Stock
|
KCN |
Re:
KCN
|
|
contrapuntal
|
153 |
53K |
2 |
02/02/25 |
02/02/25 |
ASX - By Stock
|
153
|
53K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
contrapuntal
|
1.7K |
947K |
5 |
05/01/25 |
05/01/25 |
ASX - By Stock
|
1.7K
|
947K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Market Cap +$7 Billion
|
|
contrapuntal
|
38 |
21K |
7 |
29/11/24 |
29/11/24 |
ASX - By Stock
|
38
|
21K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
contrapuntal
|
3.6K |
1.5M |
5 |
26/11/24 |
26/11/24 |
ASX - By Stock
|
3.6K
|
1.5M
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
contrapuntal
|
3.6K |
1.5M |
2 |
26/11/24 |
26/11/24 |
ASX - By Stock
|
3.6K
|
1.5M
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
contrapuntal
|
874 |
378K |
5 |
26/11/24 |
26/11/24 |
ASX - By Stock
|
874
|
378K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
contrapuntal
|
3.6K |
1.5M |
1 |
21/11/24 |
21/11/24 |
ASX - By Stock
|
3.6K
|
1.5M
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
contrapuntal
|
3.6K |
1.5M |
7 |
02/11/24 |
02/11/24 |
ASX - By Stock
|
3.6K
|
1.5M
|
7
|
|
ASX - By Stock
|
GRX |
Re:
Ann: Compensation and Interest of $490m in Successful Arbitration
|
|
contrapuntal
|
62 |
38K |
1 |
08/10/24 |
08/10/24 |
ASX - By Stock
|
62
|
38K
|
1
|
|
ASX - By Stock
|
GRX |
Re:
Ann: Compensation and Interest of $490m in Successful Arbitration
|
|
contrapuntal
|
62 |
38K |
3 |
08/10/24 |
08/10/24 |
ASX - By Stock
|
62
|
38K
|
3
|
|
ASX - By Stock
|
GRX |
Re:
Ann: Trading Halt
|
|
contrapuntal
|
22 |
9.0K |
3 |
08/10/24 |
08/10/24 |
ASX - By Stock
|
22
|
9.0K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
contrapuntal
|
1.7K |
947K |
6 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
1.7K
|
947K
|
6
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
contrapuntal
|
1.7K |
947K |
3 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
1.7K
|
947K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
contrapuntal
|
190 |
75K |
3 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
190
|
75K
|
3
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Green Light for Plant 1 at the Chatree Gold Mine
|
|
contrapuntal
|
168 |
66K |
8 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
168
|
66K
|
8
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Green Light for Plant 1 at the Chatree Gold Mine
|
|
contrapuntal
|
168 |
66K |
3 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
168
|
66K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
contrapuntal
|
73 |
28K |
11 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
73
|
28K
|
11
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix to Acquire ARTMS (Isotope Production Platform)
|
|
contrapuntal
|
43 |
19K |
2 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
43
|
19K
|
2
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Significant Gold Exploration Results in Thailand
|
|
contrapuntal
|
26 |
12K |
3 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
26
|
12K
|
3
|
|
ASX - By Stock
|
KCN |
Re:
Who else is coming to the AGM?
|
|
contrapuntal
|
15 |
7.1K |
5 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
15
|
7.1K
|
5
|
|
ASX - By Stock
|
KCN |
Re:
Ann: IMARC Presentation
|
|
contrapuntal
|
90 |
39K |
4 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
90
|
39K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
contrapuntal
|
1.7K |
947K |
6 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
1.7K
|
947K
|
6
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Chatree Gold Mine Update
|
|
contrapuntal
|
47 |
22K |
15 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
47
|
22K
|
15
|
|
ASX - By Stock
|
KCN |
Re:
Ann: IMARC Presentation
|
|
contrapuntal
|
90 |
39K |
4 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
90
|
39K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
PSMA-Targeting Alpha Emitter via Antibody Delivery for Prostate Cancer: Phase I 225Ac-J591
|
|
contrapuntal
|
4 |
2.1K |
9 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
4
|
2.1K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
contrapuntal
|
138 |
58K |
2 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
138
|
58K
|
2
|
|
ASX - By Stock
|
TLX |
PSMA-Targeting Alpha Emitter via Antibody Delivery for Prostate Cancer: Phase I 225Ac-J591
|
|
contrapuntal
|
4 |
2.1K |
4 |
05/11/23 |
05/11/23 |
ASX - By Stock
|
4
|
2.1K
|
4
|
|
ASX - By Stock
|
TLX |
Long-Term Nephrotoxicity of 177Lu-PSMA Radioligand Therapy
|
|
contrapuntal
|
0 |
523 |
11 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
0
|
523
|
11
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
contrapuntal
|
138 |
58K |
17 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
138
|
58K
|
17
|
|
ASX - By Stock
|
KCN |
Re:
Goodbye $1.20
|
|
contrapuntal
|
248 |
89K |
7 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
248
|
89K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
contrapuntal
|
138 |
58K |
6 |
29/10/23 |
29/10/23 |
ASX - By Stock
|
138
|
58K
|
6
|
|
ASX - By Stock
|
KCN |
Re:
Sep23 quarter predictions
|
|
contrapuntal
|
17 |
6.7K |
4 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
17
|
6.7K
|
4
|
|